| pubmed-article:3276309 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0501384 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0027788 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0002335 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0439830 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C0076362 | lld:lifeskim |
| pubmed-article:3276309 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:3276309 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3276309 | pubmed:dateCreated | 1988-2-20 | lld:pubmed |
| pubmed-article:3276309 | pubmed:abstractText | A new prostaglandin E1 analogue (TFC-612) was orally given to streptozocin-diabetic rats for 4 weeks after the induction of diabetes and its effects on motor nerve conduction velocity were studied. The compound significantly prevented a decrease of the velocity but did not reverse abnormal sorbitol and myo-inositol contents of the sciatic nerve. The results suggest that TFC-612 has a potent effect on diabetic nerve dysfunction via other mechanism than the correction of sorbitol and myo-inositol metabolisms and could be a potential compound for therapy of diabetic polyneuropathy. | lld:pubmed |
| pubmed-article:3276309 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3276309 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3276309 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3276309 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3276309 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:3276309 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:YasudaHH | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:YamashitaMM | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:ShigetaYY | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:TeradaMM | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:SonobeMM | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:MiyamotoYY | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:MotoyamaYY | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:KikkawaRR | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:AmenomoriMM | lld:pubmed |
| pubmed-article:3276309 | pubmed:author | pubmed-author:HatanakaII | lld:pubmed |
| pubmed-article:3276309 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3276309 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:3276309 | pubmed:volume | 150 | lld:pubmed |
| pubmed-article:3276309 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3276309 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:3276309 | pubmed:pagination | 225-30 | lld:pubmed |
| pubmed-article:3276309 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:meshHeading | pubmed-meshheading:3276309-... | lld:pubmed |
| pubmed-article:3276309 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3276309 | pubmed:articleTitle | A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats. | lld:pubmed |
| pubmed-article:3276309 | pubmed:affiliation | Third Department of Medicine, Shiga University of Medical Science, Japan. | lld:pubmed |
| pubmed-article:3276309 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3276309 | lld:pubmed |
